National Institute of Diabetes and Digestive and Kidney Diseases(DK15070)
National Institute of Diabetes and Digestive and Kidney Diseases(DK65066)
National Institute of Diabetes and Digestive and Kidney Diseases(DK77148)
National Institute of Diabetes and Digestive and Kidney Diseases(DK58538)
The regulation of thyroid activity and thyroid hormone (TH) secretion is based on
feedback mechanisms that involve the anterior pituitary TSH and medial basal hypothalamus
TSH-releasing hormone. Plasma T3 levels can be “sensed” directly by the anterior pituitary
and medial basal hypothalamus; plasma T4 levels require local conversion of T4 to
T3, which is mediated by the type 2 deiodinase (D2). To study D2-mediated T4 to T3
conversion and T3 production in the anterior pituitary gland, we used mouse pituitary
explants incubated with 125I-T4 for 48 hours to measure T3 production at different
concentrations of free T4. The results were compared with cultures of D1- or D2-expressing
cells, as well as freshly isolated mouse tissue. These studies revealed a unique regulation
of the D2 pathway in the anterior pituitary gland, distinct from that observed in
nonpituitary tissues. In the anterior pituitary, increasing T4 levels reduced D2 activity
slightly but caused a direct increase in T3 production. However, the same changes
in T4 levels decreased T3 production in human HSkM cells and murine C2C12 cells (both
skeletal muscle) and mouse bone marrow tissue, which reached zero at 50 pM free T4.
In contrast, the increase in T4 levels caused the pig kidney LLC-PK1 cells and kidney
fragments to proportionally increase T3 production. These findings have important
implications for both physiology and clinical practice because they clarify the mechanism
by which fluctuations in plasma T4 levels are transduced in the anterior pituitary
gland to mediate the TSH feedback mechanism.